Is BIIB or LH cheaper?

On trailing earnings, BIIB is cheaper: BIIB trades at a 21.42 P/E and LH at 23.57.

Which has grown faster, BIIB or LH?

Over the past five years, LH grew revenue faster — BIIB at a -4.80% CAGR versus LH at -1.58%.

Does BIIB or LH pay a bigger dividend?

LH pays a dividend (1.08% yield) while BIIB does not currently pay one.

Is BIIB or LH more profitable?

BIIB runs the higher net margin — BIIB at 13.92% versus LH at 6.66%.

Which has been the better investment, BIIB or LH?

Over the past 10-year, LH delivered the higher annualized total return — BIIB at -1.88% versus LH at 9.88%. Past performance doesn't predict future results.

Biogen Inc. (BIIB) vs Labcorp Holdings Inc. (LH)

BIIB leads on 9 of 15 compared metrics.

A side-by-side comparison of Biogen Inc. and Labcorp Holdings Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 15, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Labcorp Holdings Inc.

$21.69B

$266.16Healthcare

Total return — BIIB vs LH

growth of $100 · last 30y

BIIB +4787.8%LH +1439.9%BIIB compounded faster

BIIB LH

BIIB vs LH: by the numbers

•BIIB is the larger company ($29.22B vs $21.69B market cap).
•BIIB trades at the lower earnings multiple (21.42 vs 23.57 P/E).
•BIIB converts more revenue to profit (13.92% vs 6.66% net margin).
•LH grew revenue faster over the past five years (-1.58% vs -4.80% CAGR).
•LH pays a dividend (1.08% yield) while BIIB does not currently pay one.

Which is better, BIIB or LH?

Metric tally: BIIB 9 · LH 6

It depends on what you're optimizing for:

ValueBIIB(lower P/E)

GrowthLH(faster 5Y revenue CAGR)

QualityLH(higher ROIC)

Metrics side by side

Valuation

Metric	BIIB	LH
P/E ratio	21.42●	23.57
Forward P/E	12.26●	13.65
P/S ratio	3.01	1.56●
P/B ratio	1.59●	2.53
PEG ratio	—	1.28
EV / EBITDA	12.16●	13.73
FCF yield	8.83%●	6.27%

Profitability

Metric	BIIB	LH
Gross margin	69.77%●	27.79%
Operating margin	15.65%●	11.03%
Net margin	13.92%●	6.66%
ROE	7.36%	10.79%●
ROIC	6.62%	7.39%●

Dividends

Metric	BIIB	LH
Dividend yield	—	1.08%
Payout ratio	—	27.32%

Growth (annualized)

Metric	BIIB	LH
Revenue CAGR (5Y)	-4.80%	-1.58%●
EPS CAGR (5Y)	-18.67%	-8.00%●
FCF CAGR (5Y)	-3.59%●	-12.63%
Total return CAGR (5Y)	-12.99%	4.48%●

Frequently asked

Which is better, BIIB or LH?: It depends on your goal. value: BIIB (lower P/E); growth: LH (faster 5Y revenue CAGR); quality: LH (higher ROIC). Across all compared metrics, BIIB leads 9 to 6.
Is BIIB or LH cheaper?: On trailing earnings, BIIB is cheaper: BIIB trades at a 21.42 P/E and LH at 23.57.
Which has grown faster, BIIB or LH?: Over the past five years, LH grew revenue faster — BIIB at a -4.80% CAGR versus LH at -1.58%.
Does BIIB or LH pay a bigger dividend?: LH pays a dividend (1.08% yield) while BIIB does not currently pay one.
Is BIIB or LH more profitable?: BIIB runs the higher net margin — BIIB at 13.92% versus LH at 6.66%.
Which has been the better investment, BIIB or LH?: Over the past 10-year, LH delivered the higher annualized total return — BIIB at -1.88% versus LH at 9.88%. Past performance doesn't predict future results.

Go deeper

Full BIIB analysis Full LH analysis Interactive comparison tool

Dig into the metrics

Biogen P/E ratio Labcorp P/E ratio Biogen dividend yield Labcorp dividend yield Biogen ROE Labcorp ROE Biogen operating margin Labcorp operating margin Biogen revenue growth Labcorp revenue growth Biogen free cash flow Labcorp free cash flow

Biogen & Labcorp appear in these rankings

Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 15, 2026.